REGENERON PHARMACEUTICALS, INC. Quarterly Unrecognized Tax Benefits in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Regeneron Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2010 to Q4 2023.
  • Regeneron Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $696M, a 28.3% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $696M +$154M +28.3% Dec 31, 2023 10-K 2024-02-05
Q4 2022 $543M +$132M +32.1% Dec 31, 2022 10-K 2024-02-05
Q4 2021 $411M +$144M +53.9% Dec 31, 2021 10-K 2024-02-05
Q4 2020 $267M +$56.2M +26.7% Dec 31, 2020 10-K 2024-02-05
Q4 2019 $211M +$21.3M +11.2% Dec 31, 2019 10-K 2023-02-06
Q4 2018 $190M +$43.3M +29.6% Dec 31, 2018 10-K 2022-02-07
Q4 2017 $146M +$29M +24.7% Dec 31, 2017 10-K 2021-02-08
Q4 2016 $117M +$600K +0.52% Dec 31, 2016 10-K 2020-02-07
Q4 2015 $117M +$59M +102% Dec 31, 2015 10-K 2019-02-07
Q4 2014 $57.6M +$31M +116% Dec 31, 2014 10-K 2018-02-08
Q4 2013 $26.6M +$15.4M +136% Dec 31, 2013 10-K 2017-02-09
Q4 2012 $11.3M +$5.68M +101% Dec 31, 2012 10-K 2016-02-11
Q4 2011 $5.6M -$7.22M -56.3% Dec 31, 2011 10-K 2015-02-12
Q4 2010 $12.8M Dec 31, 2010 10-K 2014-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.